These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3623235)

  • 1. Tumor DNA content as a prognostic feature in advanced epithelial ovarian carcinoma.
    Blumenfeld D; Braly PS; Ben-Ezra J; Klevecz RR
    Gynecol Oncol; 1987 Jul; 27(3):389-402. PubMed ID: 3623235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of long-term survival by flow cytometric analysis of cellular DNA content in patients with advanced ovarian cancer.
    Friedlander ML; Hedley DW; Swanson C; Russell P
    J Clin Oncol; 1988 Feb; 6(2):282-90. PubMed ID: 3276825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of DNA content in epithelial ovarian cancer.
    Gajewski WH; Fuller AF; Pastel-Ley C; Flotte TJ; Bell DA
    Gynecol Oncol; 1994 Apr; 53(1):5-12. PubMed ID: 8175021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic significance of nuclear DNA content in malignant epithelial tumors of the ovary.
    Brescia RJ; Barakat RA; Beller U; Frederickson G; Suhrland MJ; Dubin N; Demopoulos RI
    Cancer; 1990 Jan; 65(1):141-7. PubMed ID: 2293860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of cellular DNA content on survival in ovarian carcinoma.
    Klemi PJ; Joensuu H; Mäenpää J; Kiilholma P
    Obstet Gynecol; 1989 Aug; 74(2):200-4. PubMed ID: 2748056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multivariate analysis of the prognostic significance of DNA-ploidy and S-phase fraction in ovarian cancer determined by flow cytometry following detection of cytokeratin-labeled tumor cells.
    Kimmig R; Wimberger P; Hillemanns P; Kapsner T; Caspari C; Hepp H
    Gynecol Oncol; 2002 Jan; 84(1):21-31. PubMed ID: 11748971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA flow cytometry, clinical and morphological parameters as prognostic factors for advanced malignant and borderline ovarian tumors.
    Kühn W; Kaufmann M; Feichter GE; Rummel HH; Schmid H; Heberling D
    Gynecol Oncol; 1989 Jun; 33(3):360-7. PubMed ID: 2722063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular DNA content and survival in advanced ovarian carcinoma.
    Pfisterer J; Kommoss F; Sauerbrei W; Renz H; du Bois A; Kiechle-Schwarz M; Pfleiderer A
    Cancer; 1994 Nov; 74(9):2509-15. PubMed ID: 7923008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: a prospective flow cytometric study.
    Lanza G; Gafà R; Santini A; Maestri I; Dubini A; Gilli G; Cavazzini L
    Cancer; 1998 Jan; 82(1):49-59. PubMed ID: 9428479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of cellular DNA content on survival in advanced ovarian cancer.
    Friedlander ML; Hedley DW; Taylor IW; Russell P; Coates AS; Tattersall MH
    Cancer Res; 1984 Jan; 44(1):397-400. PubMed ID: 6690054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of DNA index, multiploidy, and S-phase fraction in ovarian cancer.
    Kallioniemi OP; Punnonen R; Mattila J; Lehtinen M; Koivula T
    Cancer; 1988 Jan; 61(2):334-9. PubMed ID: 3334968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of DNA image cytometry in Libyan breast cancer.
    Ermiah E; Abdalla F; Buhmeida A; Alshrad M; Salem N; Pyrhönen S; Collan Y
    Oncology; 2012; 83(3):165-76. PubMed ID: 22906963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of DNA ploidy, S-phase fraction, and P-glycoprotein expression in colorectal cancer.
    Salud A; Porcel JM; Raikundalia B; Camplejohn RS; Taub NA
    J Surg Oncol; 1999 Nov; 72(3):167-74. PubMed ID: 10562364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cellular DNA content on the prognosis of epithelial ovarian cancers.
    Ozalp S; Yalcin OT; Gulbas Z; Tanir HM; Minsin T
    Gynecol Obstet Invest; 2001; 52(2):93-7. PubMed ID: 11586035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow cytometric analysis of DNA content in human ovarian cancers.
    Erba E; Ubezio P; Pepe S; Vaghi M; Marsoni S; Torri W; Mangioni C; Landoni F; D'Incalci M
    Br J Cancer; 1989 Jul; 60(1):45-50. PubMed ID: 2803914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of deoxyribonucleic acid ploidy and S-phase fraction as prognostic parameters in advanced epithelial ovarian carcinoma: a prospective study.
    Kaern J; Tropé CG; Kristensen GB; Tveit KM; Pettersen EO
    Am J Obstet Gynecol; 1994 Feb; 170(2):479-87. PubMed ID: 8116701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic relevance of ploidy, proliferation, and resistance-predictive tests in ovarian carcinoma.
    Volm M; Brüggemann A; Günther M; Kleine W; Pfleiderer A; Vogt-Schaden M
    Cancer Res; 1985 Oct; 45(10):5180-5. PubMed ID: 4027994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deoxyribonucleic acid content and survival rates of patients with transitional cell carcinoma of the bladder.
    al-Abadi H; Nagel R
    J Urol; 1994 Jan; 151(1):37-42. PubMed ID: 8254829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concordance of DNA ploidy pattern as measured by flow cytometry in primary, metastatic, and persistent ovarian carcinoma.
    Zanetta GM; Keeney GL; Kimlinger TK; Katzmann JA; Podratz KC
    Gynecol Oncol; 1996 Feb; 60(2):213-6. PubMed ID: 8631540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometric quantification of the proliferation-associated nuclear antigen p105 and DNA content in advanced head & neck cancers: results of RTOG 91-08.
    Fu KK; Hammond E; Pajak TF; Clery M; Doggett RL; Byhardt RW; McDonald S; Cooper JS
    Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):661-71. PubMed ID: 7913703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.